Zahabia Adenwala

Zahabia Adenwala is an experienced pharmacovigilance professional currently serving as the Director, Pharmacovigilance Scientist at Cogent Biosciences since February 2025. Previously, Zahabia held the same title at Seres Therapeutics from June 2023 to November 2024 and served as Associate Director at Bolt Biotherapeutics, Inc. from May 2022 to July 2023. Zahabia's career in pharmacovigilance began at Deciphera Pharmaceuticals, where responsibilities included Senior Manager/Senior PV Scientist and Manager, Pharmacovigilance from June 2019 to May 2022. Earlier roles included Senior Pharmacovigilance and Safety Specialist at Asahi Kasei Pharma America and Senior Safety Specialist at Fresenius Medical Care North America. Zahabia's foundational experience in drug safety began as a Safety Specialist at Amdipharm Mercury and as a Drug Safety Associate at Scientific Pharmaceutical. Zahabia holds a Master of Science in Pharmacy Administration and Pharmacy Policy and Regulatory Affairs from Northeastern University and a Bachelor of Pharmacy from Narsee Monjee Institute of Management Studies.